# Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combination-of-4-1bb-agonist-and-pd-1-antagonist-promotes-antitumor-effector/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shihao Chen,Li‐Fen Lee,Timothy S. Fisher,Bart Jessen,Mark Elliott,Winston Evering,Kathryn Logronio,Guang Huan Tu,Konstantinos Tsaparikos,Xiaoai Li,Hui Wang,Ying Chi,Mengli Xiong,Todd VanArsdale,John Lin |
| Citations | 279 |
| DOI | 10.1158/2326-6066.cir-14-0118 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://aacrjournals.org/cancerimmunolres/article-pdf/3/2/149/2348332/149.pdf |
| OpenAlex ID | https://openalex.org/W2118486765 |
| PMID | 25387892 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Mark Elliott](https://scholariq.org/researchers/mark-elliott/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.